Cbl-b Negatively Regulates B Cell Antigen Receptor Signaling in Mature B Cells through Ubiquitination of the Tyrosine Kinase Syk

Members of the Cbl family of molecular adaptors play key roles in regulating tyrosine kinase-dependent signaling in a variety of cellular systems. Here we provide evidence that in B cells Cbl-b functions as a negative regulator of B cell antigen receptor (BCR) signaling during the normal course of a response. In B cells from Cbl-b–deficient mice cross-linking the BCRs resulted in sustained phosphorylation of Igα, Syk, and phospholipase C (PLC)-γ2, leading to prolonged Ca2+ mobilization, and increases in extracellular signal–regulated kinase (ERK) and c-Jun NH2-terminal protein kinase (JNK) phosphorylation and surface expression of the activation marker, CD69. Image analysis following BCR cross-linking showed sustained polarization of the BCRs into large signaling-active caps associated with phosphorylated Syk in Cbl-b–deficient B cells in contrast to the BCRs in Cbl-b–expressing B cells that rapidly proceeded to form small, condensed, signaling inactive caps. Significantly, prolonged phosphorylation of Syk correlated with reduced ubiquitination of Syk indicating that Cbl-b negatively regulates BCR signaling by targeting Syk for ubiquitination.

[1]  T. Kurosaki,et al.  BLNK: molecular scaffolding through ‘cis’‐mediated organization of signaling proteins , 2002, The EMBO journal.

[2]  T. Kurosaki,et al.  Cbl-b Positively Regulates Btk-mediated Activation of Phospholipase C-γ2 in B Cells , 2002, The Journal of experimental medicine.

[3]  T. Kurosaki.  Regulation of B-cell signal transduction by adaptor proteins , 2002, Nature Reviews Immunology.

[4]  H. Band,et al.  Negative regulation of Lck by Cbl ubiquitin ligase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Yun-Cai Liu,et al.  Cbl and Cbl-b in T-cell regulation. , 2002, Trends in immunology.

[6]  H. Band,et al.  The non‐receptor tyrosine kinase Syk is a target of Cbl‐mediated ubiquitylation upon B‐cell receptor stimulation , 2001, The EMBO journal.

[7]  K. Coggeshall,et al.  Visualization of Negative Signaling in B Cells by Quantitative Confocal Microscopy , 2001, Molecular and Cellular Biology.

[8]  L. Frati,et al.  Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Gerra L. Bosco,et al.  Wasp recruitment to the T cell:APC contact site occurs independently of Cdc42 activation. , 2001, Immunity.

[10]  B. Brown,et al.  The Actin Cytoskeleton is Required for the Trafficking of the B Cell Antigen Receptor to the Late Endosomes , 2001, Traffic.

[11]  J. Penninger,et al.  Molecular controls of antigen receptor clustering and autoimmunity. , 2001, Trends in cell biology.

[12]  W. Langdon,et al.  Cbl: many adaptations to regulate protein tyrosine kinases , 2001, Nature Reviews Molecular Cell Biology.

[13]  A. DeFranco,et al.  Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen1 , 2001, The Journal of Immunology.

[14]  R. Geahlen,et al.  Visualization of Syk-Antigen Receptor Interactions Using Green Fluorescent Protein: Differential Roles for Syk and Lyn in the Regulation of Receptor Capping and Internalization1 , 2001, The Journal of Immunology.

[15]  K. Siminovitch,et al.  The SH2 Domain Containing Tyrosine Phosphatase-1 Down-regulates Activation of Lyn and Lyn-induced Tyrosine Phosphorylation of the CD19 Receptor in B Cells* , 2001, The Journal of Biological Chemistry.

[16]  Randall L. Kincaid,et al.  Phosphorylation of Syk Activation Loop Tyrosines Is Essential for Syk Function , 2000, The Journal of Biological Chemistry.

[17]  F. Alt,et al.  Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. , 2000, Immunity.

[18]  A. Satterthwaite,et al.  Xid-like phenotypes: a B cell signalosome takes shape. , 2000, Immunity.

[19]  J. Freed,et al.  Differential Regulation of B Cell Development, Activation, and Death by the Src Homology 2 Domain–Containing 5′ Inositol Phosphatase (Ship) , 2000, The Journal of experimental medicine.

[20]  X. Bustelo.  Regulatory and Signaling Properties of the Vav Family , 2000, Molecular and Cellular Biology.

[21]  T. Kurosaki,et al.  Cbl Suppresses B Cell Receptor–Mediated Phospholipase C (Plc)-γ2 Activation by Regulating B Cell Linker Protein–Plc-γ2 Binding , 2000, The Journal of experimental medicine.

[22]  E. Shevach,et al.  Cbl-b regulates the CD28 dependence of T-cell activation , 2000, Nature.

[23]  H. Nishina,et al.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b , 2000, Nature.

[24]  R. Mitchell,et al.  A Role for Lipid Rafts in B Cell Antigen Receptor Signaling and Antigen Targeting , 1999, The Journal of experimental medicine.

[25]  R. Geahlen,et al.  Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain. , 1999, Journal of immunology.

[26]  L. Cantley,et al.  SYK Is Upstream of Phosphoinositide 3-Kinase in B Cell Receptor Signaling* , 1999, The Journal of Biological Chemistry.

[27]  M. Turner,et al.  Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets. , 1999, Blood.

[28]  M. Naramura,et al.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Iino,et al.  Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response. , 1998, Journal of immunology.

[30]  D. Bowtell,et al.  Tissue Hyperplasia and Enhanced T-Cell Signalling via ZAP-70 in c-Cbl-Deficient Mice , 1998, Molecular and Cellular Biology.

[31]  T. Kurosaki,et al.  SHIP modulates immune receptor responses by regulating membrane association of Btk. , 1998, Immunity.

[32]  A. DeFranco,et al.  The complexity of signaling pathways activated by the BCR. , 1997, Current opinion in immunology.

[33]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB , 1996, Nature.

[34]  Marietta L. Harrison,et al.  Syk, Activated by Cross-linking the B-cell Antigen Receptor, Localizes to the Cytosol Where It Interacts with and Phosphorylates -Tubulin on Tyrosine (*) , 1996, The Journal of Biological Chemistry.

[35]  J. Hanke,et al.  Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor , 1996, The Journal of Biological Chemistry.

[36]  Victor L. J. Tybulewicz,et al.  Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk , 1995, Nature.

[37]  Tony Pawson,et al.  Syk tyrosine kinase required for mouse viability and B-cell development , 1995, Nature.

[38]  S. Pierce,et al.  Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking. , 1995, Journal of immunology.

[39]  J. Cambier,et al.  Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). , 1995, Journal of immunology.

[40]  M. Gold,et al.  Signal Transduction by the B‐Cell Antigen Receptor , 1995, Annals of the New York Academy of Sciences.

[41]  J. Cambier,et al.  The B-cell antigen receptor complex: structure and signal transduction. , 1994, Immunology today.

[42]  D. Bar-Sagi,et al.  Co-capping of ras proteins with surface immunoglobulins in B lymphocytes , 1990, Nature.

[43]  M. Raff,et al.  Normal distribution, patching and capping of lymphocyte surface immunoglobulin studied by electron microscopy. , 1973, Nature: New biology.

[44]  M. Reth,et al.  Initiation and processing of signals from the B cell antigen receptor. , 1997, Annual review of immunology.

[45]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. , 1996, Nature.

[46]  J. Small,et al.  Heparin Ii Domain of Fibronectin Mediates Contractility through an Α4β1 Co-signaling Pathway , 2010 .

[47]  A. Steinberg,et al.  Abnormalities in autologous mixed lymphocyte reaction‐activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2 , 1985, European journal of immunology.